Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K. Fielding, Anthony H. Goldstone, Susan Richards et al.|Blood|2006Cited by 843
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)Anthony H. Goldstone, Jacob M. Rowe, Susan Richards et al.|Blood|2007Cited by 782
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V. Moorman, Gordon W. Dewald, Christine J. Harrison et al.|Blood|2006Cited by 746
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationPanagiotis Kottaridis, Stephen Mackinnon, Premini Mahendra et al.|Blood|2000Cited by 502
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaChristine J. Harrison, Anthony V. Moorman, Zoë J. Broadfield et al.|British Journal of Haematology|2004Cited by 234